Mirae Asset Global ETFs Holdings’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Buy
16,187
+2,032
+14% +$36.7K ﹤0.01% 2119
2026
Q1
$248K Buy
14,155
+3,146
+29% +$60.6K ﹤0.01% 2239
2025
Q4
$146K Sell
11,009
-127
-1% -$1.13K ﹤0.01% 2495
2025
Q3
$65.5K Sell
11,136
-1,819
-14% -$8.52K ﹤0.01% 2855
2025
Q2
$53.5K Buy
12,955
+5,976
+86% +$24.1K ﹤0.01% 2867
2025
Q1
$26.2K Buy
6,979
+312
+5% +$1.44K ﹤0.01% 2952
2024
Q4
$38.6K Buy
+6,667
New +$115K ﹤0.01% 2941

Other funds holding BIOA

Mirae Asset Global ETFs Holdings's BIOA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its BioAge Labs (BIOA) stake by 14% in Q2 2026, buying an estimated $36.7K and bringing the position to 16,187 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.

Mirae Asset Global ETFs Holdings first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 16,187 shares of BioAge Labs worth $397K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,032 BioAge Labs shares in Q2 2026, an estimated $36.7K.
  • BioAge Labs made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2119 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.